In vivo generation of CAR-T cells: Current obstacles, strategic solutions, and clinical translation

Researchers discuss emerging engineering strategies for in vivo CAR-T generation, including targeted vector systems, combinatorial T-cell recognition, tunable expression control, and approaches to enhance functional durability. They also highlight recent early-phase clinical trials on in vivo CAR-T induction and discuss major barriers and future directions.